(Q37987196)

26 August 2017

title

Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain (English)

1 reference

26 August 2017

0 references

0 references

0 references

Piercarlo Sarzi-Puttini

2

object named as

Piercarlo Sarzi-Puttini

1 reference

26 August 2017

Renato Vellucci

5

0 references

Diego Fornasari

object named as

Diego Fornasari

6

0 references

Roberto Labianca

object named as

Roberto Labianca

1

0 references

author name string

Stefano Maria Zuccaro

3

1 reference

26 August 2017

Paolo Cherubino

4

1 reference

26 August 2017

publication date

1 February 2012

1 reference

Clinical Drug Investigation

26 August 2017

published in

1 reference

26 August 2017

volume

32 Suppl 1

1 reference

26 August 2017

page(s)

53-63

1 reference

Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Prevalence of pain in patients with cancer: a systematic review of the past 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Musculoskeletal pain and its socioeconomic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

The burden of neuropathic pain: results from a cross-sectional survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Side effects of opioids during short-term administration: effect of age, gender, and race

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Emergency admissions for upper gastrointestinal disease and their relation to NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Unexpected and pronounced antinociceptive synergy between spinal acetaminophen (paracetamol) and phentolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Acetaminophen hepatotoxicity and acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

An evidence-based evaluation of the gastrointestinal safety of coxibs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Renal effects of COX-2-selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Update on cyclooxygenase-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Opioids for chronic pain of non-malignant origin--caring or crippling

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Opioid Therapy for Chronic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Strategies to manage the adverse effects of oral morphine: an evidence-based report.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Differences in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Novel opioid antagonists for opioid-induced bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

A factorial trial of six interventions for the prevention of postoperative nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Opioid rotation for toxicity reduction in terminal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Opioid analgesics: comparative features and prescribing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Issues in long-term opioid therapy: unmet needs, risks, and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Multimodal approaches to optimize outcomes of chronic opioid therapy in the management of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Oral pilocarpine for treatment of opioid-induced oral dryness in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Adverse events associated with postoperative opioid analgesia: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Joint pain and quality of life; results of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11630080-000000000-00000

10.2165/11630080-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference